YOU ARE HERE > Home > News > The French Generics Market

The French Generics Market

 

Description

“The French Generics Market 2017-2022 prospects” report provides a documented, detailed and robust analysis of the French generics and biosimilars markets and evaluates the determinants of their likely evolution by 2022. 

 

 

Product details

Soft copy: 200 pages (PowerPoint)
Language: English
Price: English €5,000 (excl. tax)

Consult short version

 


Contents

1. Introduction

      2. Overview of the French generics market

2.1. Introduction
2.2. Definiton and status of generic drugs in France
2.3. The retail generics market
2.4. The OTC generics market
2.5. The hospital generics market
2.6. Stakeholders' behavior towards generics
2.7. Generics manufacturers
2.8. Marketing of generics
       
3. Essentially similar & biosimilar drugs markets
3.1. Essentially similars case studies
3.2. Essentially similars pricing
3.3. Biosimilars definition
3.4. Biosimilars prescription behavior
3.5. Evolution of biosimilar drug sales
3.6. Biosimilars pricing
 
 
4. Forecasts to 2022 and future trends
4.1. Total market
4.2. Generics
4.3. Biosimilars
4.4. Perspectives & strategic issues

5. Conclusion
 
6. Glossary